• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体显性遗传性小脑共济失调:临床特征、遗传学及发病机制

Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.

作者信息

Schöls Ludger, Bauer Peter, Schmidt Thorsten, Schulte Thorsten, Riess Olaf

机构信息

Department of Neurology, University of Tuebingen, Germany.

出版信息

Lancet Neurol. 2004 May;3(5):291-304. doi: 10.1016/S1474-4422(04)00737-9.

DOI:10.1016/S1474-4422(04)00737-9
PMID:15099544
Abstract

Autosomal dominant cerebellar ataxias are hereditary neurodegenerative disorders that are known as spinocerebellar ataxias (SCA) in genetic nomenclature. In the pregenomic era, ataxias were some of the most poorly understood neurological disorders; the unravelling of their molecular basis enabled precise diagnosis in vivo and explained many clinical phenomena such as anticipation and variable phenotypes even within one family. However, the discovery of many ataxia genes and loci in the past decade threatens to cause more confusion than optimism among clinicians. Therefore, the provision of guidance for genetic testing according to clinical findings and frequencies of SCA subtypes in different ethnic groups is a major challenge. The identification of ataxia genes raises hope that essential pathogenetic mechanisms causing SCA will become more and more apparent. Elucidation of the pathogenesis of SCA hopefully will enable the development of rational therapies for this group of disorders, which currently can only be treated symptomatically.

摘要

常染色体显性遗传性小脑共济失调是一类遗传性神经退行性疾病,在遗传学命名中被称为脊髓小脑共济失调(SCA)。在前基因组时代,共济失调是了解最少的神经系统疾病之一;其分子基础的揭示使得能够在体内进行精确诊断,并解释了许多临床现象,如遗传早现以及即使在一个家族中也存在的可变表型。然而,在过去十年中发现的许多共济失调基因和位点,给临床医生带来的困惑可能多于乐观。因此,根据临床发现以及不同种族群体中SCA亚型的发生频率提供基因检测指导是一项重大挑战。共济失调基因的鉴定让人看到希望,即导致SCA的关键致病机制将越来越清晰。阐明SCA的发病机制有望推动针对这组疾病的合理治疗方法的开发,目前这组疾病只能进行对症治疗。

相似文献

1
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.常染色体显性遗传性小脑共济失调:临床特征、遗传学及发病机制
Lancet Neurol. 2004 May;3(5):291-304. doi: 10.1016/S1474-4422(04)00737-9.
2
[The autosomal dominant cerebellar ataxias are hereditary neurodegenerative diseases].常染色体显性遗传性小脑共济失调是遗传性神经退行性疾病。
Orv Hetil. 2007 Nov 11;148(45):2125-32. doi: 10.1556/OH.2007.28205.
3
The spinocerebellar ataxias: clinical aspects and molecular genetics.脊髓小脑共济失调:临床特征和分子遗传学。
Adv Exp Med Biol. 2012;724:351-74. doi: 10.1007/978-1-4614-0653-2_27.
4
Dominant spinocerebellar ataxias: a molecular approach to classification, diagnosis, pathogenesis and the future.显性遗传性脊髓小脑共济失调:分类、诊断、发病机制及未来研究的分子学方法
Expert Rev Mol Diagn. 2003 Nov;3(6):715-32. doi: 10.1586/14737159.3.6.715.
5
[Autosomal dominant spinocerebellar ataxia].[常染色体显性遗传性脊髓小脑共济失调]
Neurol Neurochir Pol. 1999 May-Jun;33(3):633-43.
6
Recent advances in hereditary spinocerebellar ataxias.遗传性脊髓小脑共济失调的最新进展
J Neuropathol Exp Neurol. 2005 Mar;64(3):171-80. doi: 10.1093/jnen/64.3.171.
7
Identification of CAG repeat-containing genes expressed in human brain as candidate genes for autosomal dominant spinocerebellar ataxias and other neurodegenerative diseases.鉴定在人类大脑中表达的含CAG重复序列的基因为常染色体显性遗传性脊髓小脑共济失调及其他神经退行性疾病的候选基因。
J Hum Genet. 2002;47(6):275-8. doi: 10.1007/s100380200039.
8
[The genetics of spinocerebellar ataxias].[脊髓小脑共济失调的遗传学]
Nervenarzt. 2013 Feb;84(2):137-42. doi: 10.1007/s00115-012-3637-z.
9
Molecular genetics of hereditary ataxias.遗传性共济失调的分子遗传学
Baillieres Clin Neurol. 1994 Aug;3(2):281-95.
10
[Genetic diagnosis, classification and clinical hereditary ataxia disease entities].[遗传性共济失调疾病实体的基因诊断、分类及临床研究]
Fortschr Neurol Psychiatr. 1997 Feb;65(2):79-89. doi: 10.1055/s-2007-996312.

引用本文的文献

1
Advances in solid-state NMR methods for studying RNA structures and dynamics.用于研究RNA结构与动力学的固态核磁共振方法进展
Magn Reson Lett. 2024 Apr 26;5(1):200133. doi: 10.1016/j.mrl.2024.200133. eCollection 2025 Feb.
2
Glial Cells and Aging: From the CNS to the Cerebellum.神经胶质细胞与衰老:从中枢神经系统到小脑
Int J Mol Sci. 2025 Aug 5;26(15):7553. doi: 10.3390/ijms26157553.
3
7T magnetic resonance imaging-based investigation of the correlation between mammillary body structure and cognitive impairment in patients with spinocerebellar ataxia type 3.
基于7T磁共振成像对3型脊髓小脑共济失调患者乳头体结构与认知障碍相关性的研究
Psychoradiology. 2025 Jun 19;5:kkaf010. doi: 10.1093/psyrad/kkaf010. eCollection 2025.
4
Therapeutic Effects of Baroni Extract on Animal Models of Neurodegenerative Diseases Through Serotonin and HLH-30/TFEB-Dependent Mechanisms.巴罗尼提取物通过血清素和HLH-30/TFEB依赖机制对神经退行性疾病动物模型的治疗作用
Int J Mol Sci. 2025 Apr 27;26(9):4145. doi: 10.3390/ijms26094145.
5
Clinicopathological Correlations of Neurodegenerative Diseases in the National Brain Biobank of Korea.韩国国家脑库中神经退行性疾病的临床病理相关性
J Clin Neurol. 2025 May;21(3):190-200. doi: 10.3988/jcn.2024.0517.
6
Intracerebellar upregulation of Rheb(S16H) ameliorates motor dysfunction in mice with SCA2.小脑内Rheb(S16H)的上调改善了SCA2小鼠的运动功能障碍。
Acta Pharmacol Sin. 2025 Mar 3. doi: 10.1038/s41401-025-01504-y.
7
Movement Disorders in Hereditary Cerebellar Ataxia.遗传性小脑共济失调中的运动障碍
Mov Disord Clin Pract. 2025 Jun;12(6):784-795. doi: 10.1002/mdc3.14358. Epub 2025 Feb 12.
8
CRISPR/Cas9-mediated genetic correction reverses spinocerebellar ataxia 3 disease-associated phenotypes in differentiated cerebellar neurons.CRISPR/Cas9介导的基因校正可逆转分化的小脑神经元中与脊髓小脑共济失调3相关的疾病表型。
Life Med. 2022 Jun 29;1(1):27-44. doi: 10.1093/lifemedi/lnac020. eCollection 2022 Aug.
9
Gray Matter Asymmetry Alterations in Patients With Spinocerebellar Ataxia Type 3: A Voxel-Based Morphometric Comparison Study.3型脊髓小脑共济失调患者的灰质不对称性改变:一项基于体素的形态计量学比较研究。
CNS Neurosci Ther. 2024 Dec;30(12):e70171. doi: 10.1111/cns.70171.
10
Post-symptomatic administration of hMSCs exerts therapeutic effects in SCA2 mice.症状后给予 hMSCs 可发挥 SCA2 小鼠的治疗效果。
Stem Cell Res Ther. 2024 Nov 9;15(1):411. doi: 10.1186/s13287-024-04020-8.